@DrAttai @AnaBaracCardio https://t.co/irKZ20mnJw Safety of HER2 therapies in patients with LVEF 40-49%. 14 patients enrolled were treated with trastuzumab/pertuzumab. @AnaBaracCardio @claudine_isaacs @SandraSwainMD
1,322 followers
801 followers
RT @OncoCard_Ganken: @ACCinTouch #CardioOnc It's reasonable to continue or initiate HER2-targeted Tx in pts w/ mild LV dysfunction w/o a…
976 followers
@ACCinTouch #CardioOnc It's reasonable to continue or initiate HER2-targeted Tx in pts w/ mild LV dysfunction w/o a symptom of HF with close cardiac follow-up. -SAFE-HEaRt trial https://t.co/gTn51UYxmx @AnaBaracCardio Agree🤞😮 ハーセプチンは案外なんとかなります https:
801 followers
RT @OncoCard_Ganken: ■Memo Prospective evaluation of the cardiac safety of HER2-targeted Tx in pts with HER2-positive breast cancer and com…